HeteroTCR: A heterogeneous graph neural network-based method for predicting peptide-TCR interaction
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
HeteroTCR: A heterogeneous graph neural network-based method for predicting peptide-TCR interaction ; volume:7 ; number:1 ; day:4 ; month:6 ; year:2024 ; pages:1-12 ; date:12.2024
Communications biology ; 7, Heft 1 (4.6.2024), 1-12, 12.2024
- Urheber
-
Yu, Zilan
Jiang, Mengnan
Lan, Xun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s42003-024-06380-6
- URN
-
urn:nbn:de:101:1-2408112111487.057601747168
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:55 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yu, Zilan
- Jiang, Mengnan
- Lan, Xun
- SpringerLink (Online service)
Ähnliche Objekte (12)
TcR
Targeting cancers through TCR-peptide/MHC interactions
Ko-Tests: TCR
TCR‐induced alteration of primary MHC peptide anchor residue
Cytokines enhance human Vγ9Vδ2 T‐cell TCR‐dependent and TCR‐independent effector functions
Die Variabilität des Ratten iNKT TCR : = The variability of the rat iNKT TCR
Cross-TCR antagonism revealed by optogenetically tuning the half-life of the TCR ligand binding
TCR-like antibodies in cancer immunotherapy
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
An intercomparison of tropospheric ozone reanalysis products from CAMS, CAMS interim, TCR-1, and TCR-2
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release
RNAi-mediated knockdown of the endogenous TCR improves safety of immunotherapy with TCR gene-modified T cells
TcR
Targeting cancers through TCR-peptide/MHC interactions
Ko-Tests: TCR
TCR‐induced alteration of primary MHC peptide anchor residue
Cytokines enhance human Vγ9Vδ2 T‐cell TCR‐dependent and TCR‐independent effector functions
Die Variabilität des Ratten iNKT TCR : = The variability of the rat iNKT TCR
Cross-TCR antagonism revealed by optogenetically tuning the half-life of the TCR ligand binding
TCR-like antibodies in cancer immunotherapy
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
An intercomparison of tropospheric ozone reanalysis products from CAMS, CAMS interim, TCR-1, and TCR-2
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release
RNAi-mediated knockdown of the endogenous TCR improves safety of immunotherapy with TCR gene-modified T cells
TcR
Targeting cancers through TCR-peptide/MHC interactions
Ko-Tests: TCR
TCR‐induced alteration of primary MHC peptide anchor residue
Cytokines enhance human Vγ9Vδ2 T‐cell TCR‐dependent and TCR‐independent effector functions
Die Variabilität des Ratten iNKT TCR : = The variability of the rat iNKT TCR
Cross-TCR antagonism revealed by optogenetically tuning the half-life of the TCR ligand binding
TCR-like antibodies in cancer immunotherapy
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
An intercomparison of tropospheric ozone reanalysis products from CAMS, CAMS interim, TCR-1, and TCR-2
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release